Trials / Completed
CompletedNCT05918237
Pilot Study to Test the Effects of Arctiva on Mild to Moderate Eczema
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- ClinOhio Research Services, LLC · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
Up to 30 participants with mild to moderate atopic dermatitis/eczema will be enrolled to apply study Investigational Product for 4 weeks.
Detailed description
This will be a 4-week single arm study. This study will be executed by one clinical research company in one research center accruing 30 subjects with mild to moderate Eczema/atopic dermatitis. Patients ages 18-75, will be enrolled. Subjects that are enrolled will be placed on Locus's Over The Counter cream "Arctiva" twice per day for 4 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Arctiva | A colloidal oatmeal cream designed to stimulate healing and repair of damaged tissue naturally, working with the body instead of against it. |
Timeline
- Start date
- 2023-02-06
- Primary completion
- 2023-04-28
- Completion
- 2023-04-28
- First posted
- 2023-06-26
- Last updated
- 2023-06-26
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05918237. Inclusion in this directory is not an endorsement.